These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20122030)

  • 1. Differences in oncologist communication across age groups and contributions to adjuvant decision outcomes.
    Step MM; Siminoff LA; Rose JH
    J Am Geriatr Soc; 2009 Nov; 57 Suppl 2():S279-82. PubMed ID: 20122030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling patient-centered communication: oncologist relational communication and patient communication involvement in breast cancer adjuvant therapy decision-making.
    Step MM; Rose JH; Albert JM; Cheruvu VK; Siminoff LA
    Patient Educ Couns; 2009 Dec; 77(3):369-78. PubMed ID: 19811883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There a Relationship between Shared Decision Making and Breast Cancer Patients' Trust in Their Medical Oncologists?
    Engelhardt EG; Smets EMA; Sorial I; Stiggelbout AM; Pieterse AH; Hillen MA
    Med Decis Making; 2020 Jan; 40(1):52-61. PubMed ID: 31789100
    [No Abstract]   [Full Text] [Related]  

  • 4. When do cancer patients regret their treatment decision? A path analysis of the influence of clinicians' communication styles and the match of decision-making styles on decision regret.
    Nicolai J; Buchholz A; Seefried N; Reuter K; Härter M; Eich W; Bieber C
    Patient Educ Couns; 2016 May; 99(5):739-46. PubMed ID: 26658703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Does a Shared Decision-Making (SDM) Intervention for Oncologists Affect Participation Style and Preference Matching in Patients with Breast and Colon Cancer?
    Bieber C; Nicolai J; Gschwendtner K; Müller N; Reuter K; Buchholz A; Kallinowski B; Härter M; Eich W
    J Cancer Educ; 2018 Jun; 33(3):708-715. PubMed ID: 27966192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discussing adjuvant cancer therapy.
    Leighl N; Gattellari M; Butow P; Brown R; Tattersall MH
    J Clin Oncol; 2001 Mar; 19(6):1768-78. PubMed ID: 11251008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives.
    O'Neill SC; Taylor KL; Clapp J; Jayasekera J; Isaacs C; Mary Atieh Graham D; Goldberg SL; Mandelblatt J
    J Health Commun; 2018; 23(7):679-686. PubMed ID: 30130477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making.
    Kunneman M; Engelhardt EG; Ten Hove FL; Marijnen CA; Portielje JE; Smets EM; de Haes HJ; Stiggelbout AM; Pieterse AH
    Acta Oncol; 2016; 55(2):134-9. PubMed ID: 26237738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions.
    Hillyer GC; Hershman DL; Kushi LH; Lamerato L; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Rana S; Neugut AI
    Breast; 2013 Aug; 22(4):548-54. PubMed ID: 23107518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making.
    Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ
    Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment decisions for breast carcinoma: patient preferences and physician perceptions.
    Bruera E; Willey JS; Palmer JL; Rosales M
    Cancer; 2002 Apr; 94(7):2076-80. PubMed ID: 11932912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of participation in treatment decision-making by older breast cancer patients.
    Maly RC; Umezawa Y; Leake B; Silliman RA
    Breast Cancer Res Treat; 2004 Jun; 85(3):201-9. PubMed ID: 15111757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.
    Siminoff LA; Graham GC; Gordon NH
    Patient Educ Couns; 2006 Sep; 62(3):355-60. PubMed ID: 16860520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making.
    Engelhardt EG; Pieterse AH; van der Hout A; de Haes HJ; Kroep JR; Quarles van Ufford-Mannesse P; Portielje JE; Smets EM; Stiggelbout AM
    Eur J Cancer; 2016 Oct; 66():55-66. PubMed ID: 27525573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of primary care physicians in advanced cancer care: perspectives of older patients and their oncologists.
    O'Toole E; Step MM; Engelhardt K; Lewis S; Rose JH
    J Am Geriatr Soc; 2009 Nov; 57 Suppl 2(Suppl 2):S265-8. PubMed ID: 20122026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does physician communication style impact patient report of decision quality for breast cancer treatment?
    Martinez KA; Resnicow K; Williams GC; Silva M; Abrahamse P; Shumway DA; Wallner LP; Katz SJ; Hawley ST
    Patient Educ Couns; 2016 Dec; 99(12):1947-1954. PubMed ID: 27395750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.
    Wan C; Williams CP; Nipp RD; Pisu M; Azuero A; Aswani MS; Ingram SA; Pierce JY; Rocque GB
    Clin Breast Cancer; 2021 Feb; 21(1):37-46. PubMed ID: 32741667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
    Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
    Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.
    Lo SS; Mumby PB; Norton J; Rychlik K; Smerage J; Kash J; Chew HK; Gaynor ER; Hayes DF; Epstein A; Albain KS
    J Clin Oncol; 2010 Apr; 28(10):1671-6. PubMed ID: 20065191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians.
    Williams CP; Miller-Sonet E; Nipp RD; Kamal AH; Love S; Rocque GB
    Cancer; 2020 Aug; 126(15):3534-3541. PubMed ID: 32426870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.